Get started
Work

Trends in Survival Outcomes Among Patients (pts) Relapsing Early after Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) (CIBMTR Study # MM14-03)

Year: 2017
Type: article
Abstract: Background and Goals: The treatment for MM has changed dramatically over the past decade. While many prognostic factors have been described in the context of MM, the duration of response remains one of the strongest prognostic factors in pts with MM in general and specifically with ASCT.
DOI: 10.1016/j.bbmt.2016.12.040
Authors: Angela Dispenzieri, Shaji Kumar, Mei-Jie Zhang, Amrita Krishnan, Cristina Gasparetto, Yago Nieto, Raphael Fraser, Jiaxing Huang, Parameswaran Hari, Anita D'Souza
Institutions: Mayo Clinic, Medical College of Wisconsin, City Of Hope National Medical Center, City of Hope, Duke Medical Center, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2590138624
FWCI:
Cites:
Cited by:
Related to: 10